M. Walles

Publication List Details

Period

2001 - 2005

Number

14

Co-Authors

Metabolism of verapamil in cultures of rat alveolar epithelial cells and pharmacokinetics after administration by intravenous and inhalation routes (2005)

Borlak, J., Blickwede, M., Hansen, T., Koch, W., Walles, M., Levsen, K.

Administration of therapeutic entities by inhalation opens new possibilities for drug entry into systemic circulation, but this requires passage through the alveolar epithelium. Little is known about...

Multidimensional on-line sample preparation of verapamil and its metabolites by a molecularly imprinted polymer coupled to liquid chromatography-mass spectrometry (2004)

Mullet, W.M., Walles, M., Levsen, K., Borlak, J., Pawliszyn, J.

A new molecularly imprinted polymer (MIP) material was synthesized selective for verapamil and utilized for on-line metabolic screening of this common calcium antagonist in biological samples. Since...

Verapamil: Metabolism in cultures of primary human coronary arterial endothelial cells (2003)

Borlak, J., Walles, M., Levsen, K., Thum, T.

Endothelium is a metabolically active secretory tissue and an important barrier for metabolic products. Little is known about its contribution to drug oxidation. We investigated the gene and protein...

Verapamil: Identification of novel metabolites in cultures of primary human hepatocytes and human urine by LC-MS[n] and LC-NMR (2003)

Borlak, J., Walles, M., Elend, M., Thum, T., Preiss, A., Levsen, K.

1. Verapamil is a well-known and world-wide prescribed calcium antagonist, but it suffers from extensive first-pass metabolism. Although it has been marketed for many years, a complete understanding...

Metabolism of verapamil: 24 new phase I and phase II metabolites identified in cell cultures of rat hepatocytes by liquid chromatography-tandem mass spectrometry (2003)

Walles, M., Thum, T., Levsen, K., Borlak, J.

Verapamil is a widely prescribed calcium antagonist, but suffers from extensive first pass metabolism. Despite its frequent use in drug metabolism a complete understanding of its metabolic pathway is...

Application of restricted access material (RAM) with precolumn-switching and matrix solid-phase dispersion (MSPD) to the study of the metabolism and pharmacokinetics of Verapamil (2002)

Walles, M., Borlak, J., Levsen, K.

The potential of three genetic changes introduced into mice by the transgenic or knockout technology aimed at immortalizing hepatocytes in vitro and concomitantly preserving their differentiated...

Verapamil drug metabolism studies by automated in-tube solid phase microextraction (2002)

Walles, M., Mullett, W.M., Levsen, K., Borlak, J., Wünsch, G., Pawliszyn, J.

Verapamil is a common calcium antagonist described with antianginal, antihypertensive and antiarrythmic properties. The metabolites of verapamil have also shown pharmacological properties and...

Verapamil. New insight into the molecular mechanism of drug oxidation in the human heart (2002)

Walles, M., Thum, T., Levsen, K., Borlak, J.

Verapamil is a commonly prescribed cardiovascular drug, but surprisingly its metabolism in the target tissue of pharmacotherapy is basically unknown. We therefore investigated its biotransformation...

Verapamil metabolism in distinct regions of the heart and in cultures of cardiomyocytes of adult rats (2001)

Walles, M., Thum, T., Levsen, K., Borlak, J.

A substantial number of drugs act either directly or indirectly on the heart, but surprisingly, little is known about drug oxidation in the heart. We therefore investigated the metabolism of the...

Inhalation studies with the Göttingen minipig (2001)

Koch, W., Windt, H., Walles, M., Borlak, J., Clausing, P.

A method for inhalative exposure of minipigs to aerosols and gases has been developed. Minipigs are exposed via mask inhalation to the test substance using a computer-controlled exposure system that...